The failure to diagnose Mold Biotoxin Illness is not merely a clinical oversight; it is a systemic error with devastating neuro-immune consequences. Current "Standard of Care" protocols rely almost exclusively on IgE (Allergy) and IgG (Exposure) serology. This binary approach creates a massive "Diagnostic Blind Spot": it correctly identifies the allergic patient but renders the septic, neuro-toxic patient invisible.

For decades, a schism has existed in medicine regarding Mold Toxin Illness. On one side stands the mainstream medical establishment, which largely views mold exposure solely as an allergic or pulmonary event. On the other stands Dr. Ritchie Shoemaker, a primary care physician who mapped a distinct, multi-system pathology termed Chronic Inflammatory Response Syndrome (CIRS).

Every day, patients walk into clinics with a constellation of symptoms: panic attacks, sudden rage, brain fog, and treatment-resistant depression. They are prescribed SSRIs, Benzodiazepines, and Antipsychotics. They rarely get better. Why? Because they do not have a serotonin deficiency. They have a toxicity problem.